PT811001E - Dioxidos de benzotiazina como antagonistas de endotelina - Google Patents

Dioxidos de benzotiazina como antagonistas de endotelina

Info

Publication number
PT811001E
PT811001E PT96903708T PT96903708T PT811001E PT 811001 E PT811001 E PT 811001E PT 96903708 T PT96903708 T PT 96903708T PT 96903708 T PT96903708 T PT 96903708T PT 811001 E PT811001 E PT 811001E
Authority
PT
Portugal
Prior art keywords
dioxides
benzotiazine
antagonists
endothelin
preparation
Prior art date
Application number
PT96903708T
Other languages
English (en)
Inventor
Kent Alan Berryman
Amy Mae Bunker
Annette Marian Doherty
Jeremy John Edmunds
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT811001E publication Critical patent/PT811001E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
PT96903708T 1995-02-21 1996-01-26 Dioxidos de benzotiazina como antagonistas de endotelina PT811001E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/393,143 US5599811A (en) 1995-02-21 1995-02-21 Benzothiazine dioxides as endothelin antagonists

Publications (1)

Publication Number Publication Date
PT811001E true PT811001E (pt) 2002-04-29

Family

ID=23553452

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96903708T PT811001E (pt) 1995-02-21 1996-01-26 Dioxidos de benzotiazina como antagonistas de endotelina

Country Status (27)

Country Link
US (1) US5599811A (pt)
EP (1) EP0811001B1 (pt)
JP (1) JPH11501013A (pt)
KR (1) KR19980702358A (pt)
CN (1) CN1071327C (pt)
AT (1) ATE207911T1 (pt)
AU (1) AU720036B2 (pt)
BG (1) BG62613B1 (pt)
CA (1) CA2211027A1 (pt)
CZ (1) CZ294412B6 (pt)
DE (1) DE69616515T2 (pt)
DK (1) DK0811001T3 (pt)
EE (1) EE03564B1 (pt)
ES (1) ES2167544T3 (pt)
FI (1) FI973380A (pt)
GE (1) GEP20001969B (pt)
HU (1) HUP9800273A3 (pt)
NO (1) NO308897B1 (pt)
NZ (1) NZ302116A (pt)
PL (1) PL321866A1 (pt)
PT (1) PT811001E (pt)
RO (1) RO116898B1 (pt)
RU (1) RU2164225C2 (pt)
SK (1) SK284275B6 (pt)
UA (1) UA47424C2 (pt)
WO (1) WO1996026195A1 (pt)
ZA (1) ZA961342B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
EP0838223B1 (en) * 1995-06-02 2003-07-23 Shionogi & Co., Ltd. Brain edema inhibitor
US5804585A (en) * 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
HU227183B1 (en) 1997-04-28 2010-09-28 Encysive Pharmaceuticals Inc Sulfonamide derivatives and pharmaceutical compositions containing them for the treatment of endothelin-mediated disorders
CA2295239A1 (en) 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
JP2001515893A (ja) * 1997-09-05 2001-09-25 ワーナー−ランバート・カンパニー 特定のベンゾチアジンジオキシドエンドセリンアンタゴニスト類およびその製造方法
GB2337048B (en) * 1998-05-05 2000-06-28 Warner Lambert Co 2,1,3-Benzothiadiazole containing endothelin antagonists
CA2409927A1 (en) * 2000-05-31 2001-12-06 Warner-Lambert Company Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
US20020115661A1 (en) * 2000-12-07 2002-08-22 Keller Laurence Harvey Method for treating chronic obstructive pulmonary disease
BRPI0709950A2 (pt) * 2006-04-13 2011-08-02 Actelion Pharmaceuticals Ltd uso de bosentan na preparação de um medicamento para o tratamento de fibrose pulmonar idiopática em estágio precoce e uso de antagonista do receptor endotelin
FR2942797B1 (fr) * 2009-03-03 2011-04-29 Pf Medicament Derives de benzothiazines, leur preparation et leur application a titre de medicaments
JP7065081B2 (ja) 2016-09-12 2022-05-11 インテグラル ヘルス, インコーポレイテッド Gpr120モジュレーターとして有用な二環式化合物
CN112521384B (zh) * 2021-01-13 2021-11-02 湖北大学 溶剂热一锅法合成苯并噻嗪并环戊二烯衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237473A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
JPH0441483A (ja) * 1990-06-07 1992-02-12 Tanabe Seiyaku Co Ltd ベンゾチアジン誘導体及びその製法
WO1993008799A1 (en) * 1991-11-05 1993-05-13 Smithkline Beecham Corporation Endothelin receptor antagonists
US5389620A (en) * 1993-08-18 1995-02-14 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives

Also Published As

Publication number Publication date
RU2164225C2 (ru) 2001-03-20
CN1071327C (zh) 2001-09-19
KR19980702358A (ko) 1998-07-15
SK284275B6 (sk) 2004-12-01
HUP9800273A3 (en) 1999-09-28
FI973380A0 (fi) 1997-08-18
EP0811001A1 (en) 1997-12-10
MX9706024A (es) 1997-11-29
ES2167544T3 (es) 2002-05-16
DK0811001T3 (da) 2002-02-18
RO116898B1 (ro) 2001-07-30
HUP9800273A2 (hu) 1999-07-28
JPH11501013A (ja) 1999-01-26
CZ294412B6 (cs) 2004-12-15
ATE207911T1 (de) 2001-11-15
EE03564B1 (et) 2001-12-17
GEP20001969B (en) 2000-03-05
BG101867A (en) 1998-10-30
WO1996026195A1 (en) 1996-08-29
AU4770396A (en) 1996-09-11
ZA961342B (en) 1996-08-26
CN1180351A (zh) 1998-04-29
AU720036B2 (en) 2000-05-18
NO973822D0 (no) 1997-08-20
SK114697A3 (en) 1998-08-05
UA47424C2 (uk) 2002-07-15
DE69616515T2 (de) 2002-05-16
DE69616515D1 (de) 2001-12-06
CA2211027A1 (en) 1996-08-29
FI973380A (fi) 1997-08-20
NO308897B1 (no) 2000-11-13
US5599811A (en) 1997-02-04
EE9700147A (et) 1997-12-15
EP0811001B1 (en) 2001-10-31
BG62613B1 (bg) 2000-03-31
CZ260797A3 (cs) 1998-06-17
PL321866A1 (en) 1997-12-22
NO973822L (no) 1997-08-21
NZ302116A (en) 1998-06-26

Similar Documents

Publication Publication Date Title
PT811001E (pt) Dioxidos de benzotiazina como antagonistas de endotelina
ID26984A (id) Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
BR0008688A (pt) Antagonistas de il-18 recombinantes utilizáveis no tratamento de distúrbios mediados por il-18
MX9702687A (es) Antagonistas no peptidos de la endotelina.
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
ATE199554T1 (de) Zusammensetzungen zum färbung von keratinhaltigen fasern enthaltend 3-aminopyrazolo-(1,5-a)- pyrimidine, färbeverfahren, 3-aminopyrazolo-(1,5- a)-pyrimidine und ihre herstellung
EP1741713A3 (en) Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
DE69834269D1 (de) Piperidinylsubstituierte pyridylalkan-, -alken- und -alkincarbonsäuren als cytostatika und immunsuppressiva
DE69429524D1 (de) Aminocyclohexylester und ihre anwendung
DE69720062D1 (de) Integrin antagonisten
ES2151888T3 (es) Antagonistas de la endotelina.
BR9607335A (pt) Compostos 1-aril-2-acrilamino-etano e seu uso como neuroquinina especialmente antogonistas de neuroquinina 1
DE60201892D1 (en) Aminomethylpyrrolochinazoline als thrombinrezeptor-antagonist
MY116277A (en) Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
MX9304070A (es) Piperidilamidas, piperidilsulfonamidas y piperidilsulfoxamidas novedosas como inhibidores de la biosintesis del colesterol.
NO20002408D0 (no) 5-HT1F antagonister
TR199901416T2 (xx) Heterosiklik karbonikasit t�revleri.
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya